EUVIMEDDescobrir EUVIMED
Open access · CC BY-NC-ND 4.0

Evaluation of prior authorizations in transplant recipients at an urban institution

Cassie S Muran iD, Nehrin Khamo, Ruchik Patel, Shree Patel, Patricia West-Thielke, Nida Fayyaz, David Choi iD

Clinical Transplantation · 2023

DOI: 10.1111/ctr.14964 ↗

At a glance

Journal article in Clinical Transplantation, 2023. Written by Cassie S Muran and 6 co-authors. Institution: Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA. Major MEDLINE topics: Tacrolimus, Organ Transplantation. Cited 4 times so far (Crossref); 17 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

ResumoSubjectsDados bibliográficosCiteRelated studies

Abstract (original language)

Background

Increasing prior authorization (PA) requirements for immunosuppression remain a burden for solid organ transplant (SOT) recipients and transplant staff. The objective of this study was to evaluate the number of PAs required and the approval rates at an academic, urban transplant center.

Methods

This was a retrospective study of SOT recipients at the University of Illinois Hospital and Health Sciences System (UI Health) that required PAs between 11/1/2019 and 12/1/2020. Inclusion criteria were SOT recipients greater than 18 years of age and prescribed a medication by the transplant team that required PA. Duplicate PA requests were excluded from the analysis.

Results

A total of 879 PAs were included in the study. Of these PAs, 85% (747/879) were approved. Seventy‐four percent of the denials were overturned by an appeal. Most PAs were in black (45.4%), kidney transplant (62%), Medicare (31.7%), and Medicaid recipients (33.2%). The median approval time was 1 day for PAs and 5 days for appeals. Tacrolimus extended release (XR) (35.4%), tacrolimus immediate release (IR) (9.7%),and mycophenolic acid (7%) required most PAs. Black recipients and immunosuppression were identified as predictors of eventual PA approval, whereas recipients with Medicaid were less likely to obtain approval.

Conclusions

At our transplant center, there was a high approval rate of PAs for immunosuppression, which calls into question the utility of PAs in this patient population, where these medications are standard of care. More black recipients and patients with Medicare and Medicaid had increased PA requirements, highlighting further disparities within the current system.

Subjects

MeSH terms (MEDLINE)

TacrolimusOrgan TransplantationAgedHumansUnited StatesRetrospective StudiesTransplant RecipientsPrior AuthorizationMedicare

Author keywords

disparitieseconomicsimmunosuppressantinsurance

Substances

Tacrolimus

Authors and institutions

  • Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, Illinois, USA.
  • Department of Surgery, University of Illinois at Chicago, Chicago, Illinois, USA.
  • CareDx, Inc, Brisbane, California, USA.
  • Eurofins Transplant Genomics, Inc, Framingham, Massachusetts, USA.
  • Department of Pharmacy, Division of Gastroenterology and Hepatology, University of Chicago Medicine, Chicago, Illinois, USA.

ORCID profiles: Cassie S Muran, David Choi

Cite

APA

Muran, C. S., Khamo, N., Patel, R., Patel, S., West-Thielke, P., Fayyaz, N., & Choi, D. (2023). Evaluation of prior authorizations in transplant recipients at an urban institution. Clinical Transplantation. https://doi.org/10.1111/ctr.14964

Vancouver

Muran CS, Khamo N, Patel R, Patel S, West-Thielke P, Fayyaz N, et al. Evaluation of prior authorizations in transplant recipients at an urban institution. Clinical Transplantation. 2023. doi:10.1111/ctr.14964

BibTeX
@article{Muran2023,
  author = {Muran, Cassie S and Khamo, Nehrin and Patel, Ruchik and Patel, Shree and West-Thielke, Patricia and Fayyaz, Nida and Choi, David},
  title = {Evaluation of prior authorizations in transplant recipients at an urban institution},
  journal = {Clinical Transplantation},
  year = {2023},
  doi = {10.1111/ctr.14964}
}
Start for free →